AVANOS MEDICAL, INC. financial data

Symbol
AVNS on NYSE
Location
Alpharetta, GA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 24 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 242% % 6%
Quick Ratio 99% % 25%
Debt-to-equity 35% % -2.1%
Return On Equity -9.2% % 74%
Return On Assets -6.8% % 73%
Operating Margin -8.8% % 85%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 46,503,458 shares 0.56%
Common Stock, Shares, Outstanding 46,456,462 shares 1.1%
Entity Public Float $565,451,133 USD -38%
Common Stock, Value, Issued $500,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 46,300,000 shares 0.65%
Weighted Average Number of Shares Outstanding, Diluted 46,300,000 shares 0.65%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $701,200,000 USD 1.9%
Research and Development Expense $23,300,000 USD -11%
Operating Income (Loss) $61,600,000 USD 84%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $66,200,000 USD 84%
Income Tax Expense (Benefit) $6,700,000 USD
Net Income (Loss) Attributable to Parent $72,900,000 USD 81%
Earnings Per Share, Basic -1.57 USD/shares 82%
Earnings Per Share, Diluted -1.57 USD/shares 82%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $89,800,000 USD -17%
Inventory, Net $148,000,000 USD 6.6%
Assets, Current $355,400,000 USD -9.7%
Deferred Income Tax Assets, Net $33,100,000 USD 33%
Property, Plant and Equipment, Net $113,400,000 USD 2.4%
Operating Lease, Right-of-Use Asset $27,600,000 USD -19%
Intangible Assets, Net (Excluding Goodwill) $117,800,000 USD 4.9%
Goodwill $394,900,000 USD -13%
Other Assets, Noncurrent $31,500,000 USD 36%
Assets $1,073,700,000 USD -7%
Accounts Payable, Current $55,500,000 USD 2.2%
Accrued Liabilities, Current $91,300,000 USD 0%
Liabilities, Current $165,200,000 USD -0.42%
Deferred Income Tax Liabilities, Net $6,100,000 USD 11%
Operating Lease, Liability, Noncurrent $20,400,000 USD -17%
Other Liabilities, Noncurrent $13,500,000 USD 207%
Liabilities $295,500,000 USD -9.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax $32,000,000 USD 28%
Retained Earnings (Accumulated Deficit) $779,900,000 USD -10%
Stockholders' Equity Attributable to Parent $778,200,000 USD -6.1%
Liabilities and Equity $1,073,700,000 USD -7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $25,700,000 USD
Net Cash Provided by (Used in) Financing Activities $29,100,000 USD -4057%
Net Cash Provided by (Used in) Investing Activities $9,100,000 USD -355%
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $10,700,000 USD 10%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $89,800,000 USD -17%
Deferred Tax Assets, Valuation Allowance $4,700,000 USD 21%
Deferred Tax Assets, Gross $66,900,000 USD 13%
Operating Lease, Liability $28,600,000 USD -19%
Depreciation $19,700,000 USD -3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $60,300,000 USD 85%
Property, Plant and Equipment, Gross $265,500,000 USD 6.5%
Operating Lease, Liability, Current $8,200,000 USD -25%
Lessee, Operating Lease, Liability, to be Paid, Year Two $4,700,000 USD -36%
Lessee, Operating Lease, Liability, to be Paid, Year One $8,400,000 USD -25%
Operating Lease, Weighted Average Discount Rate, Percent 0.059 pure 5.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three $4,100,000 USD 5.1%
Deferred Tax Assets, Operating Loss Carryforwards $7,100,000 USD -15%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $3,400,000 USD -2.9%
Additional Paid in Capital $1,691,900,000 USD 0.79%
Amortization of Intangible Assets $126,300,000 USD 413%
Depreciation, Depletion and Amortization $9,600,000 USD -16%
Deferred Tax Assets, Net of Valuation Allowance $62,200,000 USD 12%
Share-based Payment Arrangement, Expense $12,600,000 USD -8.7%
Interest Expense $14,600,000 USD 20%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%